Drug breakthrough in skin cancer treatment
Scientists at the University of East Anglia have made a breakthrough in the treatment of skin cancer.
They have discovered that a drug commonly used to treat rheumatoid arthritis also inhibits the growth of malignant melanoma.
It could be on the market within three years.
Clive Lewis reports.